Start of CMA Merger Investigation: Anticipated acquisition by Eurofins Forensics Lux Holding Sarl (Eurofins) of DNACO Limited (Cellmark)
The Competition and Markets Authority (CMA) is considering whether it is or may be the case that this transaction, if carried into effect, will result in the creation of a relevant merger situation under the merger provisions of the Enterprise Act 2002 and, if so, whether the creation of that merger may be expected to result in a substantial lessening of competition within any market or markets in the United Kingdom for goods or services.
The CMA announced the launch of its merger inquiry by notice to the Parties on 18 July 2024 and has a deadline of 13 September 2024 for its phase 1 decision.
Invitation to comment: closes 1 August 2024
To assist it with this assessment, the CMA invites comments on the transaction from any interested party.
These comments should be provided by the deadline set out above to:
Your name and contact details are your personal data. In collecting, receiving, storing, accessing and using your personal data, the CMA, as controller, is processing your personal data. The CMA processes personal data in accordance with data protection law. The CMA is processing your personal data so that it can contact you again, should it need further help or information from you, in order to carry out its merger work under Part 3 of the Enterprise Act 2002. For more information about how the CMA processes personal data and your rights relating to that data, please see our Privacy Notice.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
